Clinical Trial Update: Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis [Phase 4]

View source ↗

Summary

A Phase 4 study assessing pancreatic tissue penetration of meropenem (Meronem) for prophylaxis of septic complications in severe pancreatitis; the trial has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Meronem (meropenem)

Snippet

Sponsor: Pfizer | Conditions: Pancreatitis | Phase 4 | Status: COMPLETED